Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion type Assertion NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_head.
- NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion description "[As the number of therapeutic molecules that modulate the expression and activity of eNOS increases, further detailed research is required to reveal their mode of action in preventing and/or reversing the endothelial dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_provenance.
- NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion evidence source_evidence_literature NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_provenance.
- NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion SIO_000772 22198555 NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_provenance.
- NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion wasDerivedFrom befree-2016 NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_provenance.
- NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_assertion wasGeneratedBy ECO_0000203 NP949216.RAwZk5Mqg52mccqDSof55b09EVj41GwXywwWaZtXpZPAk130_provenance.